Early research shows potential CLL drug with peculiar properties

Preclinical research out of the University of Ireland, Galway, hints at a molecule with the potential to do incredible things for people diagnosed with chronic lymphocytic leukemia (CLL).

Researchers discovered that the molecule, known as PHA-767491 has some peculiar qualities when it meets up with circulating leukemia cells, qualities that other treatments in many cases have lacked, for one reason or another, such as:

-- Not only does it kill basic leukemic cells, it also appears to kill leukemic cells that have features often associated with chemotherapy resistance-- a potentially major step forward;
-- It also can target leukemic cells that are undergoing cell division within the lymph nodes, cells that typically are beyond the reach of current treatment modalities and often wind up serving as hiding reservoirs for progressively treatment-resistant cells.

Researchers were sufficiently convinced of the molecule's efficacy that they applied for and were granted a Phase I clinical trial of the molecule's parent compound at the HRB Clinical Research Facility at NUI Galway.

The reader should keep in mind that many different molecules prove effective at killing cancer cells in the lab and in animal studies but very few reach actual human trials.

Source: Medical News Today
Check out: The HRB Clinical Research Facility at NUI Galway

More Articles

More Articles

Mantle cell lymphoma (MCL) is a rare type of B-Cell lymphoma. It presents itself in the mantle zone of lymph nodes...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Indolent Lymphoma, or Indolent Non-Hodgkin’s Lymphomas (NHLs), are slow growing, low-grade cancers (as opposed to ...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

Lymphomas are classified based on the type of cells involved. Non-Hodgkin’s lymphomas are marked by mutations of...

Hodgkin's Lymphoma (Disease) has a colorful history: It was not the first cancer discovered but it was one of the first in which treatments were...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Cancer bracelets are undeniably popular, and if purchased through reliable sources such as major charities, they help contribute to the fight...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer of the b- and t-cell lymphocytes, part of the immune system. They account for the most frequent head and neck malignancies....

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

As a kind of cancer, lymphoma attacks the lymphocytes and lymph nodes that are part of the immune system. Head and neck lymphoma results when...

Some cancers have clear environmental causes. Oral cancer is strongly tied to the use of chewing tobacco, and lung cancer is well-known to be much...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...